Ascorbic acid prevents cigarette smoke injury to endothelium-dependent arterial relaxation.

BACKGROUND Arterial endothelium-dependent acetylcholine relaxation is impaired by smoking, and this injury may be mediated by oxygen free radicals. The purpose of this study was to examine the effect of ascorbic acid (AA) treatment on this injury. MATERIALS AND METHODS New Zealand White rabbits (n = 6, each group) were placed in a 240-ft3 airflow chamber for 3 h per day, 5 days per week over an 8-week period. Animals were divided into four groups and fed rabbit chow and water or rabbit chow and AA (250 ml/kg)-supplemented water. The control-smoke rabbit group and the ascorbic acid-smoke rabbit group were exposed to mainstream cigarette smoke from a robotic smoke generator for the 3-h period, while the control-no smoke rabbit group and ascorbic acid-no smoke rabbit group were similarly placed in the chamber without smoke. At the end of 8 weeks, rabbits were sacrificed and segments of their superficial femoral arteries were suspended from tension transducers and the maximal contraction was determined. The remaining rings were contracted to 50% of the maximum and relaxation was determined by adding acetylcholine. Groups were compared using one-way ANOVA. RESULTS Rings from control-smoke (5.13 +/- 0.21 g) and AA-smoke rabbits (6. 24 +/- 0.46 g) exhibited increased mean contraction to KCl (P < 0. 05) compared to control-no smoke rabbits (3.86 +/- 0.40 g). Acetylcholine-dependent relaxation was significantly reduced in the rings from the control-smoke rabbits compared to control-no smoke rabbits (acetylcholine, 5 x 10(-7) M: 24.7 +/- 2.7% versus 55.3 +/- 8.0%; acetylcholine, 7 x 10(-7) M: 27.5 +/- 2.3% versus 56.3 +/- 9. 2%). The AA-smoke group (acetylcholine, 5 x 10(-7) M: 61.8 +/- 12. 4%; 7 x 10(-7) M: 67.9 +/- 11.4%) had significantly increased relaxation compared to the control-smoke group (P < 0.05). There was no statistical difference in the mean percentage ring relaxation between the control-no smoke, AA-no smoke, and AA-smoke groups. CONCLUSIONS Ascorbic acid protected the artery from cigarette smoke-induced endothelial injury.

[1]  J. Freischlag,et al.  Smoking Cessation Reverses Arterial Endothelium-Dependent Relaxation Injury , 1998 .

[2]  J. Freischlag,et al.  Combined exposure to cigarette smoke and hypercholesterolemia decreases vasorelaxation of the aorta. , 1997, Journal of vascular surgery.

[3]  J. Nielsen,et al.  Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. , 1997, The American journal of clinical nutrition.

[4]  P. Vanhoutte,et al.  Vascular endothelium: vasoactive mediators. , 1996, Progress in cardiovascular diseases.

[5]  J. Cohn,et al.  Effects of long-term cigarette smoking on endothelium-dependent responses in humans. , 1996, The American journal of cardiology.

[6]  H. Just,et al.  Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. , 1996, Circulation.

[7]  P. Gresele,et al.  Smoking and impaired endothelium-dependent dilatation. , 1996, The New England journal of medicine.

[8]  G. Levine,et al.  Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.

[9]  J. Deanfield,et al.  Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.

[10]  D. Mikhailidis,et al.  Cigarette smoking and cardiovascular disease , 1995, Journal of the Royal Society of Health.

[11]  J. Freischlag,et al.  Cigarette smoke exposure injures arterial endothelium , 1995 .

[12]  H. Lehr,et al.  Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Higman,et al.  Reversibility of smoking‐induced endothelial dysfunction , 1994, The British journal of surgery.

[14]  K. Stoschitzky,et al.  Diminished Vascular Response to Inhibition of Endothelium‐Derived Nitric Oxide and Enhanced Vasoconstriction to Exogenously Administered Endothelin‐1 in Clinically Healthy Smokers , 1994, Circulation.

[15]  W. Edwards,et al.  Endothelin in human congestive heart failure. , 1994, Circulation.

[16]  K. Kugiyama,et al.  Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. , 1994, The American journal of physiology.

[17]  D. Celermajer,et al.  Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.

[18]  G. Buettner.  The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. , 1993, Archives of biochemistry and biophysics.

[19]  B. Ames,et al.  Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. , 1991, The Biochemical journal.

[20]  D. Harats,et al.  Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. , 1990, Atherosclerosis.

[21]  B. Ames,et al.  Ascorbate is an outstanding antioxidant in human blood plasma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[23]  W. Pryor,et al.  Free-radical chemistry of cigarette smoke and its toxicological implications. , 1985, Environmental health perspectives.

[24]  William A. Pryor,et al.  Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. , 1983, Environmental health perspectives.

[25]  J. Freischlag,et al.  Cigarette smoke impairs endothelium-dependent relaxation in rabbit superficial femoral veins. , 1999, The Journal of surgical research.

[26]  G. D. De Meyer,et al.  Vascular endothelial dysfunction. , 1997, Progress in cardiovascular diseases.